Preparation method of lipid wrapped solid drug nano particle

A nanoparticle and drug technology, applied in the field of biomedicine, can solve the problem of low drug loading of nano drugs, achieve the effect of small batch-to-batch differences and great application prospects

Active Publication Date: 2018-12-07
SUN YAT SEN UNIV
View PDF9 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the nano-drugs prepared by the rapid nano-preci

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of lipid wrapped solid drug nano particle
  • Preparation method of lipid wrapped solid drug nano particle
  • Preparation method of lipid wrapped solid drug nano particle

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0032] Example 1 Preparation of methotrexate nanoparticle solution

[0033] Weigh methotrexate, dissolve it in a mixed solvent of N,N-dimethylformamide and N-methylpyrrolidone (volume ratio 7:3), and prepare a 4 mg / mL organic solution of methotrexate. It is introduced into the first channel of the four-channel vortex mixer, and ultrapure water is introduced into the other three channels to achieve rapid turbulent mixing to prepare the methotrexate nanoparticle solution. The volume ratio of the organic methotrexate solution and the aqueous phase is 1:3 to 9, respectively, and the flow rate of the organic phase is 6 mL / min.

[0034] When the volume ratio of the organic methotrexate solution (organic phase) and the aqueous phase is changed, methotrexate nanoparticles with different particle sizes can be prepared. The specific ratio and particle size relationship are as follows: figure 1 As shown in the figure, it can be seen from the figure that when the volume ratio of the orga...

Example Embodiment

[0037] Example 2 Preparation of lipid-encapsulated methotrexate nanoparticles

[0038]Weigh 1,2-dioleoyl-SN-glycerol-3-phosphorylethanolamine (DOPE), cholesterol succinate monoester (CHEMS), 1,2-distearyl-SN-glycerol-3-phosphorylethanolamine -Polyethylene glycol (2000) (DSPE-PEG), made into a mixture in a molar ratio of 10:9:1, dissolved in dichloromethane to make a 10 mg / mL mixed lipid solution for later use. Quantitatively pipette 0.1 mL of mixed lipid dichloromethane solution into 10 mL of 4% ethanol solution, and the solution is sonicated with a probe sonicator until it is clear for use. After mixing the lipid ethanol solution of equal volume and the methotrexate nanoparticle solution with a particle size of 49.1 nm prepared in Example 1, the mass ratio of methotrexate and the mixed lipid in the mixed solution was 4:1, and the mixed solution was mixed. The liquid was repeatedly extruded 7 times through a 100-nm polyvinylidene fluoride membrane to obtain lipid-encapsulated...

Example Embodiment

[0045] Example 3 Preparation of lipid-encapsulated chlorambucil or doxorubicin nanoparticles

[0046] Weigh chlorambucil or doxorubicin and dissolve them in dimethyl sulfoxide or N,N-dimethylformamide, respectively, to prepare an organic solution of 1 mg / mL or 0.5 mg / mL, respectively, and introduce them into The first channel of the four-channel vortex mixer, and the other three channels introduce ultrapure water to achieve fast turbulent mixing to prepare chlorambucil nanoparticle solution and doxorubicin nanoparticle solution. Among them, the volume ratio of the chlorambucil nanoparticle solution (organic phase) or the doxorubicin nanoparticle solution (organic phase) and the aqueous phase was set to 1:3 to 11, respectively, and the flow rate of the organic phase was 10 mL / min. A chlorambucil nanoparticle solution and a doxorubicin nanoparticle solution were obtained.

[0047] Referring to the steps in Example 2, lipid-coated chlorambucil nanoparticles and lipid-coated doxo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a preparation method of a lipid wrapped solid drug nano particle. The preparation method comprises following steps: at first, preparing a drug nano particle solution from an amphiphilic small molecular drug by a rapid nano precipitation method without adding any stabilizing agent; mixing the drug nano particle solution with a lipid solution, and extruding the mixed solutionto prepare the lipid wrapped solid drug nano particle. Compared with a conventional drug nano particle, the provided lipid wrapped solid drug nano particle has an ultrahigh drug loading capacity, which can reach 60% or more and is obviously higher than that of a conventional drug nano particle. Moreover, the preparation method is continuous, the difference between different batches is small, andthe preparation method is suitable for industrial production. Furthermore, the surface of the drug particle is wrapped by lipid, thus the nano particle can be stably stored for a long term, at the same time, the tumor tissue targeting performance and pH responding property are also enhanced, and the preparation method has a wide application prospect in drug delivery.

Description

technical field [0001] The invention belongs to the field of biomedicine, and more specifically relates to a method for preparing lipid-coated solid drug nanoparticles. Background technique [0002] Although the nano-chemotherapy drug delivery system has improved the curative effect and prolonged the patient's survival time to a certain extent, cancer is still one of the diseases that threaten human health the most. So far, although nano-drug preparations are being developed and produced, and even approved for clinical use, most nano-drugs have a fatal flaw, that is, their drug loading is low, usually less than 10%; in addition, some carriers used in nano-medicines have no efficacy and may even produce toxic and side effects; and the preparation process of nano-medicines often involves cumbersome processes or complex chemical synthesis, resulting in poor reproducibility of different batches and difficulty in large-scale Industrial production. [0003] Rapid nanoprecipitati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/51A61K47/24A61K47/28A61K47/34A61K31/519A61K31/196A61K31/704A61P35/00
CPCA61K9/5123A61K9/5146A61K31/196A61K31/519A61K31/704A61P35/00
Inventor 曾志鹏陈永明刘利新赵鹏飞
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap